Comparison of Post-transplant Cyclophosphamide Containing Immunosuppressive Regimen with Standard Immunosuppressive Regimen in Allogeneic Stem Cell Transplantation from Matched Sibling Donor

Aim:Allogeneic stem cell transplantation (ASCT) is the only treatment that can cure most of malignant hematological diseases with the risk of some serious complications such as graft-versus-host disease (GVHD). GVHD can be got under control with post-transplant cyclophosphamide even in patients with...

Full description

Bibliographic Details

Published in:	Namık Kemal Tıp Dergisi
Main Authors:	Osman KARA, Tayfun ELİBOL
Format:	Article
Language:	English
Published:	Tekirdağ Namık Kemal University 2021-12-01
Subjects:	allogeneic stem cell transplant graft-versus-host disease cyclophosphamide
Online Access:	http://namikkemalmedj.com/archives/archive-detail/article-preview/comparison-of-post-transplant-cyclophosphamide-con/49752